Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing Buprenorphine listed with Health Canada. Original Data : Health Canada Website

Client Email

Product

Buprenorphine
ORP-101
CAS 52485-79-7
Buprenorphine Hydrochloride
3-O-Methyl Norbuprenorphine
CAS 16196-70-6
CAS 78715-23-8
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Buprenorphine Header

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

SCI PHARMTECH Buprenorphine

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Buprenorphine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

33 API Suppliers, 12 USDMF, 11 CEP/COS, 2 JDMF, 4 EU WC, 13 NDC API, 23 Listed Suppliers, $ API Reference Price

33 API Suppliers
12 USDMF
11 CEP/COS
2 JDMF
4 EU WC
13 NDC API
23 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

13 API Suppliers

13 API Suppliers

FINISHED DOSAGE FORMULATIONS

268 FDF Dossiers, 39 FDA Orange Book, 117 Europe, 6 Canada, 63 Australia, 7 South Africa, 36 Listed Dossiers

268 FDF Dossiers
39 FDA Orange Book
117 Europe
6 Canada
63 Australia
7 South Africa
36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 10MCG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 15MCG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 20MCG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 5MCG/HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 7.5MCG/HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 10MCG/HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 15MCG/HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 20MCG/HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 5MCG/HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 7.5MCG/HR

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 12 SPI Pharma, 2 Seqens, 1 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 6 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 28 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 24 Direct Compression, 24 Controlled & Modified Release, 17 Taste Masking, 15 Granulation, 14 Thickeners and Stabilizers, 12 Solubilizers, 12 Chewable & Orodispersible Aids, 10 Parenteral, 10 Lubricants & Glidants, 9 Co-Processed Excipients, 8 Film Formers & Plasticizers, 7 Topical, 6 Disintegrants & Superdisintegrants, 5 Empty Capsules, 5 API Stability Enhancers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Rheology Modifiers

58 Fillers, Diluents & Binders
42 Coating Systems & Additives
24 Direct Compression
24 Controlled & Modified Release
17 Taste Masking
15 Granulation
14 Thickeners and Stabilizers
12 Solubilizers
12 Chewable & Orodispersible Aids
10 Parenteral
10 Lubricants & Glidants
9 Co-Processed Excipients
8 Film Formers & Plasticizers
7 Topical
6 Disintegrants & Superdisintegrants
5 Empty Capsules
5 API Stability Enhancers
4 Emulsifying Agents
4 Vegetarian Capsules
2 Coloring Agents
1 Rheology Modifiers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 192 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
192 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 94 Finished Drug Prices

1 US Medicaid Prescriptions
94 Finished Drug Prices

MARKET PLACE

11 APIs, 5 FDF Dossiers

11 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

96 US Patents, 7 US Exclusivities, 7 Health Canada Patents

96 US Patents
7 US Exclusivities
7 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 20 Others

2 EDQM
1 USP
20 Others

$ API Ref.Price (USD/KG) : 15,127 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 2INDIVIOR UK LIMITED

02 4PURDUE PHARMA

filter Active Ingredients Reset all filters

6 All

01 6BUPRENORPHINE

filter Dosage Form Reset all filters

6 All

01 4PATCH

02 2SOLUTION (EXTENDED RELEASE)

filter Brand Name Reset all filters

6 All

01 1BUTRANS 10

02 1BUTRANS 15

03 1BUTRANS 20

04 1BUTRANS 5

05 2SUBLOCADE

Temad Buprenorphine

FDF Dossiers
FDA Orange Book
Europe
Canada
Australia
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

INDIVIOR UK LIMITED

Formnext Forum

Not Confirmed

INDIVIOR UK LIMITED

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

BUPRENORPHINE

Brand Name : SUBLOCADE

Dosage Form : SOLUTION (EXTENDED RELEASE)

Dosage Strength : 300MG/1.5ML

Packaging : 1.5ML

Approval Date :

Application Number : 2483092

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

INDIVIOR UK LIMITED

Formnext Forum

Not Confirmed

INDIVIOR UK LIMITED

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

BUPRENORPHINE

Brand Name : SUBLOCADE

Dosage Form : SOLUTION (EXTENDED RELEASE)

Dosage Strength : 100MG/0.5ML

Packaging : 0.5ML

Approval Date :

Application Number : 2483084

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

PURDUE PHARMA

Formnext Forum

Not Confirmed

PURDUE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

BUPRENORPHINE

Brand Name : BUTRANS 15

Dosage Form : PATCH

Dosage Strength : 15MCG/HOUR

Packaging : 4 X 18.75 SQ CM

Approval Date :

Application Number : 2450771

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

PURDUE PHARMA

Formnext Forum

Not Confirmed

PURDUE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

BUPRENORPHINE

Brand Name : BUTRANS 5

Dosage Form : PATCH

Dosage Strength : 5MCG/HOUR

Packaging : 4

Approval Date :

Application Number : 2341174

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

PURDUE PHARMA

Formnext Forum

Not Confirmed

PURDUE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

BUPRENORPHINE

Brand Name : BUTRANS 20

Dosage Form : PATCH

Dosage Strength : 20MCG/HOUR

Packaging : 4

Approval Date :

Application Number : 2341220

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

PURDUE PHARMA

Formnext Forum

Not Confirmed

PURDUE PHARMA

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

BUPRENORPHINE

Brand Name : BUTRANS 10

Dosage Form : PATCH

Dosage Strength : 10MCG/HOUR

Packaging : 4

Approval Date :

Application Number : 2341212

Regulatory Info : Narcotic (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?